Additionally, ASCO recommends that patients undergoing BRCA1/2 testing should be considered for additional testing for other cancer predisposition genes based on their personal or family history, with consultation from providers skilled in clinical cancer genetics to aid in decision-making (Formal Consensus; Agreement: 90%) [22]. The gene discussed is BRCA1; the disease is cancer.